Longeveron (LGVN) announced the appointment of Lisa Locklear as Executive Vice President and Chief Financial Officer. The appointment is effective as of July 31, 2023. Locklear joins Longeveron from Avanir Pharmaceuticals, a subsidiary of Otsuka (OTSKY), where she served as Senior Vice President and CFO.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LGVN: